Innovative Treatments for Vitreoretinal Conditions

 

Innovations in Vitreoretinal Surgery

At Podeh Company, we are proud to be at the forefront of developing groundbreaking devices and methods for vitreoretinal surgeries. Our innovations are designed to enhance precision, improve patient outcomes, and reduce the risks associated with complex retinal procedures.

Key Innovations:

  1. Intravitreal Balloons (Nanomaterial and Controllable)

    • We have developed intravitreal balloons made from advanced nanomaterials. These balloons are injected into the vitreous space using a specialized injector, helping to stabilize the retina during delicate surgeries. The controllable nature of the balloon allows surgeons to adjust its size and positioning, preventing complications and assisting in retinal treatments and transplants.

  2. Retinal Forceps for Membrane Peeling

    • Our newly designed retinal forceps are tailored for the precise peeling of membranes during vitreoretinal procedures. These forceps provide better control and minimize trauma to the delicate retinal tissues, improving surgical success and patient recovery times.

  3. Buckling Material with Adjustable Intraocular Pressure Control

    • We have introduced an innovative buckling material for retinal detachment surgeries. This material is uniquely controllable, allowing surgeons to adjust the intraocular pressure during the procedure. This ensures a more precise and stable outcome, while minimizing the risk of complications post-surgery.

Conclusion

At Podeh Company, we continue to push the boundaries of vitreoretinal surgery with our advanced devices and techniques. Our commitment to innovation ensures that surgeons have the tools they need to deliver safer, more effective outcomes for patients with retinal diseases and conditions.

Properties of the invention for vitreoretinal surgery

  • This innovative device, designed specifically for vitreoretinal surgery, offers a range of advanced functions and capabilities. It holds patents in three countries, including the United States.

  • It has been recognized as the best invention in ophthalmology festivals by a panel of experts.

  • The invention introduces groundbreaking advancements in vitreoretinal surgery, including its potential to assist in retinal transplantation.

  • It features a specialized scaffold that supports stem cell transplantation, aiding in tissue regeneration.

  • The device is capable of stimulating retinal and optic nerve cells, promoting faster recovery post-surgery.

  • It also offers a potential treatment for amblyopia (lazy eye).

  • Equipped with its own sensors, the invention can monitor and control the progress of treatment, ensuring optimal outcomes.

  • Additionally, it reduces the risk of complications after surgery and helps prevent glaucoma following vitreoretinal procedures.

  • Highly Profitable: With potential for international sales, this innovative device can offer significant company profitability and expand its market reach and impact.